Hologic volatility elevated into Q4 and Gen-Probe acquisition outlook Hologic November put option implied volatility is at 68, December is at 42, January is at 37; compared to its 26-week average of 35 according to Track Data, suggesting larger near term price movement into the release of Q4 results on November 12.
News For HOLX From The Last 14 Days
Check below for free stories on HOLX the last two weeks.
Hologic receives FDA approval for low-dose 3D mammography solution Hologic announced that the FDA approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography screening exam.
Leerink's medical devices analyst holds a conference call Medical Devices Analyst Newitter discusses Hologic's tomosynthesis (3D) technology on an Analyst/Industry conference call to be held on May 16 at 2:30 pm.
On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: Aeropostale (ARO) downgraded to Sell from Hold at Brean Capital... AIG (AIG) downgraded to Neutral from Buy at Goldman... Alpha Natural (ANR) downgraded to Sell from Neutral at Goldman... American Eagle (AEO) downgraded to Market Perform from Outperform at Wells Fargo... Coach (COH) downgraded to Market Perform from Outperform at Wells Fargo... Iconix Brand (ICON) downgraded to Hold from Buy at Brean Capital... International Rectifier (IRF) downgraded to Market Perform at JMP Securities... Mettler-Toledo (MTD) downgraded to Hold from Buy at Jefferies... TJX (TJX) downgraded to Market Perform from Outperform at Wells Fargo... Tiffany (TIF) downgraded to Market Perform from Outperform at Wells Fargo... North American Palladium (PAL) downgraded to Market Perform at Raymond James... Ducommun (DCO) downgraded to Neutral from Buy at B. Riley... International Rectifier (IRF) downgraded at JMP Securities... Hologic (HOLX) downgraded to Buy from Strong Buy at ISI Group... Ruckus Wireless (RKUS) downgraded to Neutral from Buy at Lazard Capital.
Subscribe for More Information
